Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/12/1990 | EP0386688A1 Method for preparing hydrogel preparations and xerogel preparations |
09/12/1990 | EP0386614A1 Cell growth enhancers and/or antibody production stimulators comprising chemically modified hydrophilic polyurea-urethane prepolymers and polymers |
09/12/1990 | EP0386441A1 Calcium therapy treatment for milk fever |
09/12/1990 | EP0386440A1 Medicament with controlled release of the active ingredient |
09/12/1990 | EP0217146B1 W/o creams containing hydrocortisone diesters |
09/12/1990 | EP0209547B1 Drug-containing chlorofluorocarbon aerosol propellent formulations |
09/11/1990 | US4956454 Monoclonal antibody - platinum co-ordination compound complex |
09/11/1990 | US4956453 Anti-human ovarian cancer immunotoxins and methods of use thereof |
09/11/1990 | US4956386 Pharmaceutical compositions and process for their preparation |
09/11/1990 | US4956354 Therapeutic preparation for use on skin |
09/11/1990 | US4956351 Antiviral pharmaceutical compositions containing cyclodextrins |
09/11/1990 | US4956171 Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
09/11/1990 | CA2048993A1 Molecular cloning of genomic and cdna sequences encoding cellular receptors for poliovirus |
09/11/1990 | CA1273878A1 Nicotine-containing preparation for transdermal administration |
09/11/1990 | CA1273871A1 Transdermal nitroglycerin delivery system |
09/10/1990 | CA2011919A1 A drug-release controlling coating material for long acting formulations |
09/09/1990 | CA2007137A1 Agent for desensitizing man and/or animals against an allergen |
09/08/1990 | WO1990010448A2 Covalent conjugates of lipid and oligonucleotide |
09/08/1990 | CA2049028A1 Covalent conjugates of lipid and oligonucleotide |
09/08/1990 | CA2011772A1 Aerosol compositions for the imaging, the diagnostic and the targetted therapy of inflammatory and tumoral sites |
09/08/1990 | CA2011682A1 Method for preparing hydrogel preparations and exrogel preparations |
09/07/1990 | WO1990010871A1 Assay for and treatment of autoimmune diseases |
09/07/1990 | WO1990010082A1 Chymopapain fragmentation of monoclonal antibodies |
09/07/1990 | WO1990010021A1 Solubilization of indomethacin and piroxicam by a quaternized polymer |
09/07/1990 | WO1990009803A1 Compositions having specific cytolytic properties in relation to appropriate target cells and their applications |
09/07/1990 | WO1990009799A1 GnRH ANALOGS FOR DESTROYING GONADOTROPHS |
09/07/1990 | WO1990009797A1 Orally administerable calcium supplement for cattle |
09/07/1990 | WO1990009782A1 Liposome gel composition and method |
09/07/1990 | CA2049007A1 Assay for and treatment of autoimmune diseases |
09/07/1990 | CA2011423A1 Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
09/06/1990 | CA2011365A1 Diluent formulation for daptomycin |
09/05/1990 | EP0385601A2 Cross-linked antibodies and processes for their preparation |
09/05/1990 | EP0385468A1 A stabilized antitumor composition |
09/05/1990 | EP0385396A1 Organosiloxane-containing polysaccharides |
09/05/1990 | EP0385385A2 Human monocyte-machrophage-CSF preparations |
09/05/1990 | EP0385335A2 Stabilized fat-soluble vitamin compositions |
09/05/1990 | EP0384976A2 Glycerophospholipid composition having enhanced surface-active properties |
09/05/1990 | EP0346501A4 Pharmaceutical preparation for treating immunodeficiency conditions |
09/05/1990 | EP0343239A4 Glassy matrix for administration of beneficial agent |
09/05/1990 | EP0246294B1 Use of a hydrophobic substance for preparing an enteric preparation for treatment of obesity and an enteric preparation |
09/04/1990 | US4954638 Leukotriene by amides and hydrazides |
09/04/1990 | US4954532 Cosmetic formulaton |
09/04/1990 | US4954526 Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
09/04/1990 | US4954522 Lyophilized preparation of platinum compound |
09/04/1990 | US4954487 Antiinflammatory agent, alcohol, propylene glycol, ester |
09/04/1990 | US4954351 Method of producing standardized povidone iodine preparations and such preparations |
09/04/1990 | US4954350 Controlled release antihistamine; coating mixture containing ethyl cellulose and a (meth)acrylate polymer |
09/04/1990 | US4954347 Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
09/04/1990 | CA1273578A1 Basic formulations of quinolonecarboxylic acids |
09/04/1990 | CA1273575A1 Pharmaceutical compositions consisting of acylated phospholipids |
09/04/1990 | CA1273570A1 Antibody conjugates |
09/02/1990 | WO1990009796A1 Solid preparation of activated vitamin d3 having improved stability |
09/02/1990 | CA2011246A1 Hydrolysis degradable polyester-silicone solids copolymers |
08/29/1990 | WO1990009785A1 Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents |
08/29/1990 | EP0384769A2 Protein labelling |
08/29/1990 | EP0384624A2 Cross-linked antibodies and processes for their preparation |
08/29/1990 | EP0384514A2 Dual-action tablet |
08/29/1990 | EP0384283A2 Pharmaceutical for rectal application and process for its preparation |
08/29/1990 | EP0383803A1 Oligonucleotide-polyamide conjugates |
08/29/1990 | EP0383799A1 Adheson variants |
08/28/1990 | US4952687 Fatty acid esters of sugars and sugar alcohols |
08/28/1990 | US4952676 Monoclonal antibody-platinum co-ordination compound complex |
08/28/1990 | US4952575 Solutions of oxaphosphorins having improved stability and process for the preparation thereof |
08/28/1990 | US4952566 Stabilized anthracycline preparation containing L-cysteine |
08/28/1990 | US4952565 Inclusion complex of ibuproxam with beta-cyclodextrin, a process for preparing the same and a pharmaceutical preparation containing the same |
08/28/1990 | US4952563 Waterfree application form of low molecular weight alkali huminates |
08/28/1990 | US4952560 Ointment base |
08/28/1990 | US4952394 Drug-monoclonal antibody conjugates |
08/28/1990 | CA1273295A1 Chewable capsules |
08/26/1990 | WO1990009780A1 Drug delivery compositions |
08/25/1990 | WO1990010020A1 Novel compositions containing hyaluronic acid associates and a process for preparing same |
08/25/1990 | WO1990009786A1 Heterologous block oligomers |
08/25/1990 | CA2028153A1 Heterologous block oligomers |
08/24/1990 | WO1990009809A1 Percutaneous drug delivery system |
08/24/1990 | WO1990009781A1 Therapeutic aerosol formulations |
08/24/1990 | CA2050905A1 Therapeutic aerosol formulations |
08/24/1990 | CA2027590A1 Percutaneous drug delivery system |
08/23/1990 | WO1990009413A1 Electrotransport adhesive |
08/23/1990 | WO1990009401A1 Crosslinked hyaluronate gels, their use and method for producing them |
08/23/1990 | WO1990009167A1 Composition and method for administration of pharmaceutically active substances |
08/23/1990 | WO1990006115A3 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
08/23/1990 | DE4005190A1 Neue cyclosporinhaltige galenische formen New cyclosporin galenic form |
08/23/1990 | DE3903753A1 Verfahren zur herstellung waessriger mischmicelloesungen A process for the preparation of aqueous mixed micelle |
08/22/1990 | EP0383680A2 Pentamidine solutions |
08/22/1990 | EP0383599A2 Protein anti-cancer agent |
08/22/1990 | EP0383569A2 Storage of materials |
08/22/1990 | EP0383540A2 Oily paste composition |
08/22/1990 | EP0383481A2 Anesthetic oral compositions |
08/22/1990 | EP0383363A2 Use of wound healing agents |
08/22/1990 | EP0383170A2 Methotrexate linked to polymers, process for their preparation, and use |
08/22/1990 | EP0383024A2 N-polyhydroxy-N'-alkyl urea derivatives, process for their preparation and their use |
08/22/1990 | EP0382875A1 Dispersant for biologically active peptide |
08/22/1990 | EP0382796A1 Method for the preparation of antibody-fragment conjugates |
08/22/1990 | CN1044761A Prolonged release of biologically active polyepeptides |
08/21/1990 | US4950738 Anticarcinogens |
08/21/1990 | US4950713 Anti tumor agents, aids therapy |
08/21/1990 | US4950654 Hydrophilic theophylline powder formulation and its preparation |
08/21/1990 | US4950599 Genetic engineering |
08/21/1990 | US4950484 Amphoteric beta-lactam antibiotic and cellulose disintegrants |
08/21/1990 | US4950480 Enhancement of antigen immunogenicity |